Our firm represented a minority equityholder in the sale of a communications company serving clients primarily in the biopharmaceutical industry to a private equity firm operating primarily in the health care industry.
October 2016
Our firm represented a minority equityholder in the sale of a communications company serving clients primarily in the biopharmaceutical industry to a private equity firm operating primarily in the health care industry.